Cellectis SA (CLLS)
Cellectis Market Cap : 399.35M for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| EDAP TMS SA | 177.99M |
| DBV Technologies SA | 1.174B |
| Ascendis Pharma A/S | 13.81B |
| Akari Therapeutics Plc | 11.08M |
| Biodexa Pharmaceuticals Plc | 0.9647M |
Market Cap Related Metrics
| PS Ratio | 4.937 |
| Price to Book Value | 3.974 |
| Price | 3.97 |
| Earnings Yield | -8.40% |